老年患者接受减重手术后癌症与心血管疾病的发病率
该研究为基于丹麦、芬兰、瑞典的人群队列研究,纳入1989至2019年间60岁及以上接受减重手术且无既往恶性肿瘤或心血管疾病的患者,按国家、性别、手术时年龄1:5匹配非手术治疗肥胖患者。中位随访5.8年,减重手术组与非手术组肥胖相关癌症风险(HR 0.81;95%CI 0.64-1.03)和心血管疾病风险(HR 0.86;95%CI 0.74-1.01)相似。胃旁路术(1930例)与匹配对照(9650例)相比,肥胖相关癌症风险降低(HR 0.74;95%CI 0.56-0.97),心血管疾病风险降低(HR 0.82;95%CI 0.69-0.99)。结论提示老年患者减重手术总体未降低两种结局风险,但胃旁路术可能有关联。
要点
- 60岁及以上患者减重手术与肥胖相关癌症风险无关(HR 0.81;95%CI 0.64-1.03),与心血管疾病风险无关(HR 0.86;95%CI 0.74-1.01)。
- 胃旁路术患者(1930例)肥胖相关癌症发生率3.7%(71例),匹配对照(9650例)为4.6%(442例),HR 0.74(95%CI 0.56-0.97)。
- 胃旁路术患者心血管疾病发生率8.2%(159例),匹配对照为8.9%(859例),HR 0.82(95%CI 0.69-0.99)。
- 研究纳入60岁及以上无既往恶性肿瘤或心血管疾病患者,中位随访5.8年,总体肥胖相关癌症发生率4.3%(658例),心血管疾病发生率9.4%(1436例)。
适用人群与场景
- 丹麦、芬兰、瑞典1989至2019年间60岁及以上接受减重手术、无既往恶性肿瘤或心血管疾病的患者。
- 匹配对照为同国家、同性别、手术日期时同年龄的非手术治疗肥胖患者,每例手术患者匹配5例对照。
诊断标准与关键阈值
- 肥胖相关癌症定义为乳腺癌、子宫内膜癌、食管癌、结直肠癌和肾癌的复合结局,来自国家癌症登记。
- 心血管疾病定义为心肌梗死、缺血性卒中、脑出血的复合结局,来自患者登记。
研究设计与关键结果
- 研究类型:基于丹麦、芬兰、瑞典的人群队列研究,共纳入15300例患者(中位[IQR]年龄63[61-65]岁;女性10152例[66.4%]),其中2550例(16.7%)在60岁及以上接受减重手术,12750例(83.3%)接受非手术治疗。
- 中位随访5.8(2.8-8.5)人年期间,658例(4.3%)发生肥胖相关癌症,1436例(9.4%)发生心血管疾病。
- 减重手术组与非手术组比较:肥胖相关癌症风险HR 0.81(95%CI 0.64-1.03),心血管疾病风险HR 0.86(95%CI 0.74-1.01),均相似。
- 胃旁路术亚组(1930例)与匹配对照(9650例)比较:肥胖相关癌症71例(3.7%)vs 442例(4.6%),HR 0.74(95%CI 0.56-0.97);心血管疾病159例(8.2%)vs 859例(8.9%),HR 0.82(95%CI 0.69-0.99)。
- 多变量Cox回归校正糖尿病、高血压、外周血管疾病、慢性阻塞性肺疾病、肾脏疾病和衰弱。
证据类型、等级与局限
- 证据类型:基于丹麦、芬兰、瑞典的人群队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于60岁及以上肥胖患者,减重手术总体上未显示与肥胖相关癌症或心血管疾病风险降低相关(HR 0.81;95%CI 0.64-1.03和HR 0.86;95%CI 0.74-1.01)。
- 作者认为胃旁路术可能与该人群两种结局风险降低相关(肥胖相关癌症HR 0.74;95%CI 0.56-0.97;心血管疾病HR 0.82;95%CI 0.69-0.99)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Bariatric surgery is associated with decreased risk of obesity-related cancer and cardiovascular disease but is typically reserved for patients younger than 60 years. Whether these associations hold for patients who undergo surgery at older ages is uncertain.
OBJECTIVE: To determine whether bariatric surgery is associated with a decreased risk of obesity-related cancer and cardiovascular disease in patients who underwent surgery at age 60 years or older.
DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort study of patients from Denmark, Finland, and Sweden who underwent bariatric surgery at age 60 years or older without previous malignant neoplasm or cardiovascular disease between 1989 and 2019. Each patient who underwent surgery was exactly matched to 5 patients with nonoperative treatment for obesity of the same country, sex, and age at the date of surgery. Data were analyzed in December 2023.
EXPOSURE: Receiving treatment for obesity, including bariatric surgery and nonoperative treatments.
MAIN OUTCOMES AND MEASURES: The main outcome was obesity-related cancer, defined as a composite outcome of breast, endometrial, esophageal, colorectal, and kidney cancer, identified from the national cancer registries. The secondary outcome was cardiovascular disease, defined as a composite outcome of myocardial infarction, ischemic stroke, and cerebral hemorrhage, identified from the patient registries. Multivariable Cox regression provided hazard ratios (HR) with 95% CIs adjusted for diabetes, hypertension, peripheral vascular disease, chronic obstructive pulmonary disease, kidney disease, and frailty.
RESULTS: In total, 15 300 patients (median [IQR] age, 63 [61-65] years; 10 152 female patients [66.4%]) were included, of which 2550 (16.7%) had bariatric surgery at age 60 or older and 12 750 (83.3%) had nonoperative treatment. During a median (IQR) of 5.8 (2.8-8.5) person-years of follow-up, 658 (4.3%) developed obesity-related cancer and 1436 (9.4%) developed cardiovascular disease. The risk of obesity-related cancer (HR, 0.81; 95% CI, 0.64-1.03) and cardiovascular disease (HR, 0.86; 95% CI, 0.74-1.01) were similar among who underwent surgery and those who did not. Gastric bypass (1930 patients) was associated with a decreased risk of obesity-related cancer (71 patients [3.7%]; HR, 0.74; 95% CI, 0.56-0.97) and cardiovascular disease (159 patients [8.2%]; HR, 0.82; 95% CI, 0.69-0.99) compared with matched controls (9650 patients; obesity-related cancer: 442 patients [4.6%]; cardiovascular disease: 859 patients [8.9%]).
CONCLUSIONS AND RELEVANCE: This cohort study found that bariatric surgery in older patients is not associated with lower rates of obesity-related cancer and cardiovascular events, but there was evidence that gastric bypass may be associated with lower risk of both outcomes.
参考来源
- Gerber P, Naqqar D, von Euler-Chelpin M, et al. Incidence of Cancer and Cardiovascular Disease After Bariatric Surgery in Older Patients. JAMA Netw Open. 2024. PMID: 39136945. doi:10.1001/jamanetworkopen.2024.27457
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。